HPVC2023-190 Victorian Compounded Chemotherapy & MAB Preparations Cluster
Current Contract
Description
Contract for the provision of compounded chemotherapy and monoclonal antibody (MAB) preparations to participating Victorian public health services.Additional Information
HSV wishes to announce that the HPVITS2023-190 Victorian Compounded Chemotherapy and MAB Preparations Cluster tender has now been awarded.
The contract details are:
Contract commencement date: 11 Dec 2023
Contract end date: 10 Dec 2026
Option periods: 1 x 2-year Option
Categories
Category 1: Chemotherapy medicinesCategory 2: Biologic medicines
Category 3: Containers
Category 4: Compounding
Category 5: Consumables